AstraZeneca Can't Get FDA Tip-Off On Generic Approvals
AstraZeneca PLC on Monday unsuccessfully tried to force the U.S. Food and Drug Administration to notify it before approving a generic form of its antipsychotic drug Seroquel, two days after losing...To view the full article, register now.
Already a subscriber? Click here to view full article